Research output per year
Research output per year
Personal profile
Expertises
25 years experience in the field of radiopharmaceutical sciences. Areas of expertise include development of new PET radiopharmaceuticals for research, diagnosis and for clinical trials; production and quality control of radiopharmaceuticals; metabolite analysis; cyclotron targets; good manufacturing practise (GMP); quality assurance; auditing; inspections.
Main research areas
Radiopharmaceuticals for neuroreceptor imaging with PET; radiopharmceuticals for diagnostic imaging in oncology; methods for measurement of radiometabolites; targets for the production of carbon-11 labelled gases; new methods for GMP compliant preparation of radiopharmaceuticals.
Current research
See above.
Fingerprint
Dive into the research topics where Nic Gillings is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
[18F]mFBG long axial field of view PET-CT without general anaesthesia reveals concise extension of neuroblastoma in a 9-month-old boy
Borgwardt, L., Brok, J. S., Andersen, K. F., Madsen, J., Gillings, N., Fosbøl, M. Ø., Denholt, C. L., Wehner, P. S., Enevoldsen, L. H., Oturai, P., Czyzewska, D., Johannesen, H. H., Højgaard, L., Petersen, I. N., Sørensen, L. S., Schulze, C., Saxtoft, E. S., Andersen, F. L. & Fischer, B. M., 28 Feb 2023, (E-pub ahead of print) In: European Journal of Nuclear Medicine and Molecular Imaging.Research output: Contribution to journal › Journal article › Research › peer-review
-
Correction: [18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
Marner, L., Korsholm, K., Anderberg, L., Lonsdale, M. N., Jensen, M. R., Brødsgaard, E., Denholt, C. L., Gillings, N., Law, I. & Friberg, L., 1 Mar 2023Research output: Other contribution › Research
-
[18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
Marner, L., Korsholm, K., Anderberg, L., Lonsdale, M. N., Jensen, M. R., Brødsgaard, E., Denholt, C. L., Gillings, N., Law, I. & Friberg, L., 7 Sep 2022, In: EJNMMI Research. 12, 1, p. 56 56.Research output: Contribution to journal › Journal article › Research › peer-review
-
Design Considerations for a Radiopharmaceutical Production Facility
Gillings, N., 2022, Handbook of Nuclear Medicine and Molecular Imaging for Physicists: Radiopharmaceuticals and Clinical Applications. Ljungberg, M. (ed.). Vol. 3. p. 55-58Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
-
EANM guideline on quality risk management for radiopharmaceuticals
Gillings, N., Hjelstuen, O., Behe, M., Decristoforo, C., Elsinga, P. H., Ferrari, V., Kiss, O. C., Kolenc, P., Koziorowski, J., Laverman, P., Mindt, T. L., Ocak, M., Patt, M., Todde, S. & Walte, A., Aug 2022, In: European Journal of Nuclear Medicine and Molecular Imaging. 49, 10, p. 3353-3364 12 p.Research output: Contribution to journal › Journal article › Research › peer-review